By Alex Philippidis

NEW YORK (GenomeWeb News) – Duke University Medical Center has opened a $5.3 million facility designed to apply systems biology and molecular medicine approaches to early-phase studies of new drug or medical device candidates, especially at the proof-of-concept or "first-in-human" clinical stages.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.